Compare Relay Therapeutics Inc. Common Stock (RLAY) vs Schlumberger NV (SLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Relay Therapeutics Inc. Common Stock vs Schlumberger NV — how do they compare? Relay Therapeutics Inc. Common Stock trades at $17.89 (market cap $3.82B), while Schlumberger NV trades at $48.93 (market cap $72.69B). The key difference: Schlumberger NV is far larger — about 19× Relay Therapeutics Inc. Common Stock's market cap, and Schlumberger NV pays a 2.41% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Relay Therapeutics Inc. Common Stock for 0 Days and Schlumberger NV for 99 Days on average.
| RLAY | SLB | |
|---|---|---|
Market Cap | $3.82B | $72.69B |
Volume | 4,332,079 | 16,228,451 |
Sector | Health | Energy |
52-Week High | $20.75 | $60.10 |
52-Week Low | $6.03 | $31.72 |
Typical Hold Time | 0 Days | 99 Days |
Enterprise Value | $2.93B | $81.42B |
Dividend Yield | — | 2.41% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SLB trades at $48.95, up 2.06% today, but technical indicators signal a bearish trend with key support at $48. The company reported revenue of $35.71B in 2025 with a net income margin of 8.53%, though margins have softened from prior years. Recent contract wins in Oman and Mozambique bolster long-term revenue visibility, while analyst consensus remains strongly bullish with an average price target of $64.58.
The stock presents a value opportunity given analyst optimism and strategic contract expansions, but faces headwinds from declining profit margins and bearish technical momentum. Earnings beats in recent quarters support fundamental strength, yet investors must weigh execution risks against the potential for significant upside relative to the current price.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →About Schlumberger NV
Schlumberger is the largest oilfield service firm in the world, with expertise in myriad disciplines, including reservoir performance, well construction, production enhancement, and more recently, digital solutions. It maintains a reputation as one of the industry's leading innovators, which has earned it dominant share in numerous end markets.
Read more on SLB →
